146 research outputs found
Treatment with rapamycin or rapamycin in combination with metformin contributes to mechanisms of mitochondrial proteostasis in vivo and in vitro
2018 Spring.Includes bibliographical references.This dissertation describes three sets of experiments with an overall objective of understanding how lifespan-extending treatments influence mechanisms of mitochondrial protein homeostasis (proteostasis). The specific aims of the three experiments were to 1) determine how the mTORC1 inhibitor rapamycin (Rap), or the anti-diabetes medication metformin in combination with rapamycin (Met+Rap) influence mitochondrial protein synthesis in young mice, and to determine if there are sex-specific differences in protein synthesis following treatment with Rap or Met+Rap; 2) examine the influence of Met+Rap treatment on protein synthesis in the heart, liver, and skeletal muscle of older mice and to determine if there are sex-specific differences in protein synthesis following Met+Rap treatment in old mice; 3) and, finally, to investigate the regulation of how protein turnover contributes to maintaining proteostasis during Rap and Met+Rap treatment, and the contribution of autophagic and mitophagic flux to protein turnover in cultured skeletal myotubes. In the first experiment, both Rap and Met+Rap treatments lowered mitochondrial protein synthesis in male mice compared to control in skeletal muscle. However, in female mice, only Met+Rap treatment significantly lowered skeletal muscle mitochondrial protein synthesis compared to control. Additionally, both Rap and Met+Rap treatments significantly elevated skeletal muscle mitochondrial protein synthesis in female animals compared to males. However, in the heart and liver tissue, there were no differences in mitochondrial protein synthesis between treatments or sexes. In the second experiment, Met+Rap treatment lowered protein synthesis in all three tissues, but in a fraction-specific manner. independent of sex-differences in old mice. For the third experiment, we measured protein synthesis and protein breakdown in cultured skeletal myotubes treated with Rap and Met+Rap. Rap treatment significantly increased mitochondrial protein:DNA compared to control, while Met+Rap did not. We demonstrate that autophagic flux is a large (29%) contributing process to degradation of mitochondrial proteins. Additionally, mitochondrial fission is not essential for mitochondrial protein degradation. The data from these experiments demonstrate that despite sexually dimorphic effects on lifespan, Rap and Met+Rap treatments both enhance the contribution of protein synthesis to maintaining proteostasis in vivo. Further, we demonstrate that both Rap and Met+Rap treatment increased protein:DNA in cultured skeletal myotubes. In summary, these data demonstrate that Rap and Met+Rap treatments increase proteostatic mechanisms, and further research is required to improve the understanding of how Met+Rap treatment influences lifespan
Recommended from our members
Radiative absorption enhancements by black carbon controlled by particle-to-particle heterogeneity in composition.
Black carbon (BC) absorbs solar radiation, leading to a strong but uncertain warming effect on climate. A key challenge in modeling and quantifying BC's radiative effect on climate is predicting enhancements in light absorption that result from internal mixing between BC and other aerosol components. Modeling and laboratory studies show that BC, when mixed with other aerosol components, absorbs more strongly than pure, uncoated BC; however, some ambient observations suggest more variable and weaker absorption enhancement. We show that the lower-than-expected enhancements in ambient measurements result from a combination of two factors. First, the often used spherical, concentric core-shell approximation generally overestimates the absorption by BC. Second, and more importantly, inadequate consideration of heterogeneity in particle-to-particle composition engenders substantial overestimation in absorption by the total particle population, with greater heterogeneity associated with larger model-measurement differences. We show that accounting for these two effects-variability in per-particle composition and deviations from the core-shell approximation-reconciles absorption enhancement predictions with laboratory and field observations and resolves the apparent discrepancy. Furthermore, our consistent model framework provides a path forward for improving predictions of BC's radiative effect on climate
Comparison of In-Situ, Model and Ground Based In-Flight Icing Severity
As an aircraft flies through supercooled liquid water, the liquid freezes instantaneously to the airframe thus altering its lift, drag, and weight characteristics. In-flight icing is a contributing factor to many aviation accidents, and the reliable detection of this hazard is a fundamental concern to aviation safety. The scientific community has recently developed products to provide in-flight icing warnings. NASA's Icing Remote Sensing System (NIRSS) deploys a vertically--pointing Ka--band radar, a laser ceilometer, and a profiling multi-channel microwave radiometer for the diagnosis of terminal area in-flight icing hazards with high spatial and temporal resolution. NCAR s Current Icing Product (CIP) combines several meteorological inputs to produce a gridded, three-dimensional depiction of icing severity on an hourly basis. Pilot reports are the best and only source of information on in-situ icing conditions encountered by an aircraft. The goal of this analysis was to ascertain how the testbed NIRSS icing severity product and the operational CIP severity product compare to pilot reports of icing severity, and how NIRSS and CIP compare to each other. This study revealed that the icing severity product from the ground-based NASA testbed system compared very favorably with the operational model-based product and pilot reported in-situ icing
LSST Science Book, Version 2.0
A survey that can cover the sky in optical bands over wide fields to faint
magnitudes with a fast cadence will enable many of the exciting science
opportunities of the next decade. The Large Synoptic Survey Telescope (LSST)
will have an effective aperture of 6.7 meters and an imaging camera with field
of view of 9.6 deg^2, and will be devoted to a ten-year imaging survey over
20,000 deg^2 south of +15 deg. Each pointing will be imaged 2000 times with
fifteen second exposures in six broad bands from 0.35 to 1.1 microns, to a
total point-source depth of r~27.5. The LSST Science Book describes the basic
parameters of the LSST hardware, software, and observing plans. The book
discusses educational and outreach opportunities, then goes on to describe a
broad range of science that LSST will revolutionize: mapping the inner and
outer Solar System, stellar populations in the Milky Way and nearby galaxies,
the structure of the Milky Way disk and halo and other objects in the Local
Volume, transient and variable objects both at low and high redshift, and the
properties of normal and active galaxies at low and high redshift. It then
turns to far-field cosmological topics, exploring properties of supernovae to
z~1, strong and weak lensing, the large-scale distribution of galaxies and
baryon oscillations, and how these different probes may be combined to
constrain cosmological models and the physics of dark energy.Comment: 596 pages. Also available at full resolution at
http://www.lsst.org/lsst/sciboo
Concurrent capecitabine and upper abdominal radiation therapy is well tolerated
We retrospectively evaluated acute toxicity in 88 patients that were treated with capecitabine and concurrent radiotherapy to the upper abdomen. These patients included 28 (32%) with pancreatic adenocarcinoma, 18 (20%) with cholangiocarcinoma, 11 (13%) with ampullary carcinoma, 11 (13%) with other primary tumors, 14 (16%) with liver metastases, and 6 (7%) with metastases at other sites. The median dose of radiotherapy was 45 Gy (range 30–72 Gy). The median dose of capecitabine was 850 mg/m(2 )twice daily, with 77% receiving 800–900 mg/m(2 )twice daily. The highest grade of acute toxicity was Common Terminology Criteria (CTC) grade 0 in 5 (6%), grade 1 in 60 (68%), grade 2 in 18 (20%), and grade 3 in 5 (6%) patients. No patient had CTC grade 4 toxicity. The most common grade 2 toxicities were nausea, hand-foot syndrome, fatigue, anorexia and diarrhea. The grade 3 toxicities included nausea, vomiting and fatigue. Three patients (3%) required hospitalization due to grade 3 acute toxicity. Capecitabine was interrupted, discontinued or given at an adjusted dose in 13 (15%) patients because of acute toxicity. Therefore, capecitabine and concurrent radiotherapy to the upper abdomen appears to be well tolerated. Capecitabine may serve as an alternative to bolus or infusional 5-FU during chemoradiation for upper gastrointestinal malignancies
LSST: from Science Drivers to Reference Design and Anticipated Data Products
(Abridged) We describe here the most ambitious survey currently planned in
the optical, the Large Synoptic Survey Telescope (LSST). A vast array of
science will be enabled by a single wide-deep-fast sky survey, and LSST will
have unique survey capability in the faint time domain. The LSST design is
driven by four main science themes: probing dark energy and dark matter, taking
an inventory of the Solar System, exploring the transient optical sky, and
mapping the Milky Way. LSST will be a wide-field ground-based system sited at
Cerro Pach\'{o}n in northern Chile. The telescope will have an 8.4 m (6.5 m
effective) primary mirror, a 9.6 deg field of view, and a 3.2 Gigapixel
camera. The standard observing sequence will consist of pairs of 15-second
exposures in a given field, with two such visits in each pointing in a given
night. With these repeats, the LSST system is capable of imaging about 10,000
square degrees of sky in a single filter in three nights. The typical 5
point-source depth in a single visit in will be (AB). The
project is in the construction phase and will begin regular survey operations
by 2022. The survey area will be contained within 30,000 deg with
, and will be imaged multiple times in six bands, ,
covering the wavelength range 320--1050 nm. About 90\% of the observing time
will be devoted to a deep-wide-fast survey mode which will uniformly observe a
18,000 deg region about 800 times (summed over all six bands) during the
anticipated 10 years of operations, and yield a coadded map to . The
remaining 10\% of the observing time will be allocated to projects such as a
Very Deep and Fast time domain survey. The goal is to make LSST data products,
including a relational database of about 32 trillion observations of 40 billion
objects, available to the public and scientists around the world.Comment: 57 pages, 32 color figures, version with high-resolution figures
available from https://www.lsst.org/overvie
Fasting and surgery timing (FaST) audit
Background & aimsInternational guidance advocates the avoidance of prolonged preoperative fasting due to its negative impact on perioperative hydration. This study aimed to assess the adherence to these guidelines for fasting in patients undergoing elective and emergency surgery in the East Midlands region of the UK.MethodsThis prospective audit was performed over a two-month period at five National Health Service (NHS) Trusts across the East Midlands region of the UK. Demographic data, admission and operative details, and length of preoperative fasting were collected on adult patients listed for emergency and elective surgery.ResultsOf the 343 surgical patients included within the study, 50% (n = 172) were male, 78% (n = 266) had elective surgery and 22% (n = 77) underwent emergency surgery. Overall median fasting times (Q1, Q3) were 16.1 (13.0, 19.4) hours for food and 5.8 (3.5, 10.7) hours for clear fluids. Prolonged fasting >12 h was documented in 73% (n = 250) for food, and 21% (n = 71) for clear fluids. Median fasting times from clear fluids and food were longer in the those undergoing emergency surgery when compared with those undergoing elective surgery: 13.0 (6.4, 22.6) vs. 4.9 (3.3, 7.8) hours, and 22.0 (14.0, 37.4) vs. 15.6 (12.9, 17.8) hours respectively, p < 0.0001.ConclusionsDespite international consensus on the duration of preoperative fasting, patients continue to fast from clear fluids and food for prolonged lengths of time. Patients admitted for emergency surgery were more likely to fast for longer than those having elective surgery
Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial
Chemotherapy combined with immunotherapy has improved the treatment of certain solid tumors, but effective regimens remain elusive for pancreatic ductal adenocarcinoma (PDAC). We conducted a randomized phase 2 trial evaluating the efficacy of nivolumab (nivo; anti-PD-1) and/or sotigalimab (sotiga; CD40 agonistic antibody) with gemcitabine/nab-paclitaxel (chemotherapy) in patients with first-line metastatic PDAC (NCT03214250). In 105 patients analyzed for efficacy, the primary endpoint of 1-year overall survival (OS) was met for nivo/chemo (57.7%, P = 0.006 compared to historical 1-year OS of 35%, n = 34) but was not met for sotiga/chemo (48.1%, P = 0.062, n = 36) or sotiga/nivo/chemo (41.3%, P = 0.223, n = 35). Secondary endpoints were progression-free survival, objective response rate, disease control rate, duration of response and safety. Treatment-related adverse event rates were similar across arms. Multi-omic circulating and tumor biomarker analyses identified distinct immune signatures associated with survival for nivo/chemo and sotiga/chemo. Survival after nivo/chemo correlated with a less suppressive tumor microenvironment and higher numbers of activated, antigen-experienced circulating T cells at baseline. Survival after sotiga/chemo correlated with greater intratumoral CD4 T cell infiltration and circulating differentiated CD4 T cells and antigen-presenting cells. A patient subset benefitting from sotiga/nivo/chemo was not identified. Collectively, these analyses suggest potential treatment-specific correlates of efficacy and may enable biomarker-selected patient populations in subsequent PDAC chemoimmunotherapy trials
- …